NCT05764525

Efficacy and Safety of VVZ-149 Injections in Patients Undergoing Laparoscopic Colectomy

A Phase 3, Multicenter, Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of VVZ-149 Injections for the Treatment of Postoperative Pain Following Laparoscopic Colectomy

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 285 (actual)
• Sponsor: Vivozon Pharmaceutical Inc. · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this phase 3 study is to evaluate the efficacy and safety of VVZ-149 Injections for the treatment of postoperative pain following laparoscopic colectomy.

Conditions

• Pain, Postoperative
• Acute Pain

Interventions

Type	Name	Description
DRUG	VVZ-149 Injections	IV infusion of 1000 mg of VVZ-149
DRUG	Placebo	IV infusion of 0 mg of VVZ-149

Timeline

• Start date: 2021-07-19
• Primary completion: 2022-11-03
• Completion: 2022-11-22
• First posted: 2023-03-10
• Last updated: 2025-02-20
• Results posted: 2025-02-20

Locations

5 sites across 1 country: South Korea

Regulatory

• FDA-regulated drug study